Search research articles
Contact Us
Filters
Showing results (71-80 of 77) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 77 results.
Oncogene
|
August 12, 2014
GD3 synthase regulates epithelial-mesenchymal transition and metastasis in breast cancer
T R Sarkar, V L Battula, S J Werden, et al.
The Pharmacogenomics Journal
|
March 23, 2002
Integrating genotype and phenotype information: an overview of the PharmGKB project. Pharmacogenetics Research Network and Knowledge Base
T E Klein, J T Chang, M K Cho, et al.
Alimentary Pharmacology & Therapeutics
|
July 22, 2014
Validated gene expression biomarker analysis for biopsy-based clinical trials in ulcerative colitis
B S Boland, D L Boyle, W J Sandborn, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 19, 2021
High tumor mutation burden fails to predict immune checkpoint blockade response across all cancer types
D J McGrail, P G Pilié, N U Rashid, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 14, 2000
Randomized trial of neoadjuvant cisplatin, vincristine, bleomycin, and radical hysterectomy versus radiation therapy for bulky stage IB and IIA cervical cancer
T C Chang, C H Lai, J H Hong, et al.
Oncogene
|
January 26, 2016
Inhibition of FOXC2 restores epithelial phenotype and drug sensitivity in prostate cancer cells with stem-cell properties
A N Paranjape, R Soundararajan, S J Werden, et al.
Oncogene
|
June 14, 2016
Phosphorylation of serine 367 of FOXC2 by p38 regulates ZEB1 and breast cancer metastasis, without impacting primary tumor growth
S J Werden, N Sphyris, T R Sarkar, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 77) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 77 results.
Oncogene
|
August 12, 2014
GD3 synthase regulates epithelial-mesenchymal transition and metastasis in breast cancer
T R Sarkar, V L Battula, S J Werden, et al.
The Pharmacogenomics Journal
|
March 23, 2002
Integrating genotype and phenotype information: an overview of the PharmGKB project. Pharmacogenetics Research Network and Knowledge Base
T E Klein, J T Chang, M K Cho, et al.
Alimentary Pharmacology & Therapeutics
|
July 22, 2014
Validated gene expression biomarker analysis for biopsy-based clinical trials in ulcerative colitis
B S Boland, D L Boyle, W J Sandborn, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 19, 2021
High tumor mutation burden fails to predict immune checkpoint blockade response across all cancer types
D J McGrail, P G Pilié, N U Rashid, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 14, 2000
Randomized trial of neoadjuvant cisplatin, vincristine, bleomycin, and radical hysterectomy versus radiation therapy for bulky stage IB and IIA cervical cancer
T C Chang, C H Lai, J H Hong, et al.
Oncogene
|
January 26, 2016
Inhibition of FOXC2 restores epithelial phenotype and drug sensitivity in prostate cancer cells with stem-cell properties
A N Paranjape, R Soundararajan, S J Werden, et al.
Oncogene
|
June 14, 2016
Phosphorylation of serine 367 of FOXC2 by p38 regulates ZEB1 and breast cancer metastasis, without impacting primary tumor growth
S J Werden, N Sphyris, T R Sarkar, et al.
Page
of 8